Targeted magnetic pulses aim to lift bipolar depression

NCT ID NCT07680153

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether a non-invasive brain stimulation technique called rTMS can improve depression in people with bipolar disorder. Researchers use brain scans to create a personalized map for each participant, targeting the exact brain circuits involved in mood shifts. Participants receive both active and sham (placebo) stimulation in random order to compare effects. The goal is to see if this tailored approach can restore communication between brain regions and reduce depressive symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
repetitive transcranial magnetic stimulation (rTMS)
What this could lead to
If it works, this could point toward a more effective, non-invasive treatment for depression in bipolar disorder that is tailored to each person's brain.
What could go wrong
This is a small, early-phase trial testing a new targeting method, so results may not apply broadly. rTMS can cause scalp discomfort or headache, and the sham comparison helps control for placebo effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR 1 DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Weill Cornell Medicine

    New York, New York, 10065, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.